Recombinant Humanized antibody to dabigatran
Figure 1 Pharmacokinetic data.
Geometric mean idarucizumab plasma concentration-time profiles from the start of a single infusion of 1 g to 4 g idarucizumab for 5 minutes on (A) a linear scale and (B) a semi-log scale.
Reilly, P. A., van Ryn, J., Grottke, O., Glund, S., & Stangier, J. (2016). Idarucizumab, a specific reversal agent for dabigatran: mode of action, pharmacokinetics and pharmacodynamics, and safety and efficacy in phase 1 subjects. The American journal of medicine, 129(11), S64-S72.
Figure 2 Effect of idarucizumab or placebo infusion on coagulation variables, (A) dTT, (B) ECT, (C) aPTT and (D) TT.
Dotted horizontal lines show upper limit of normal. "0 h" and the arrows on x axes show when the idarucizumab or placebo infusion ended. Solid horizontal lines show the mean baseline measurement. Data points show mean; error bars show standard error. aPTT = activated partial thromboplastin time; DE = dabigatran etexilate; dTT = diluted thrombin time; ECT = ecarin clotting time.
Reilly, P. A., van Ryn, J., Grottke, O., Glund, S., & Stangier, J. (2016). Idarucizumab, a specific reversal agent for dabigatran: mode of action, pharmacokinetics and pharmacodynamics, and safety and efficacy in phase 1 subjects. The American journal of medicine, 129(11), S64-S72.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
CAT | Product Name | Application | Type |
---|---|---|---|
PABZ-167 | Mouse Anti-Dabigatran Recombinant Antibody (clone 15C9) | ELISA, Neut | Mouse IgG |
HPAB-1507-FY | Human Anti-Dabigatran Recombinant Antibody (HPAB-1507-FY) | Neut, ELISA | Chimeric (mouse/human) IgG |
HPAB-1508-FY | Human Anti-Dabigatran Recombinant Antibody (HPAB-1508-FY) | Neut, ELISA | Chimeric (mouse/human) IgG |
HPAB-1509-FY | Human Anti-Dabigatran Recombinant Antibody (HPAB-1509-FY) | Neut, ELISA | Chimeric (mouse/human) IgG |
CAT | Product Name | Application | Type |
---|---|---|---|
PFBZ-167 | Mouse Anti-Dabigatran Recombinant Antibody (clone 15C9); Fab Fragment | ELISA, Neut | Mouse Fab |
HPAB-1507-FY-F(E) | Mouse Anti-Dabigatran Recombinant Antibody; Fab Fragment (HPAB-1507-FY-F(E)) | Neut, ELISA | Mouse Fab |
HPAB-1508-FY-F(E) | Mouse Anti-Dabigatran Recombinant Antibody; Fab Fragment (HPAB-1508-FY-F(E)) | Neut, ELISA | Mouse Fab |
HPAB-1509-FY-F(E) | Mouse Anti-Dabigatran Recombinant Antibody; Fab Fragment (HPAB-1509-FY-F(E)) | Neut, ELISA | Mouse Fab |
CAT | Product Name | Application | Type |
---|---|---|---|
PSBZ-167 | Mouse Anti-Dabigatran Recombinant Antibody (clone 15C9); scFv Fragment | ELISA, Neut | Mouse scFv |
HPAB-1507-FY-S(P) | Mouse Anti-Dabigatran Recombinant Antibody; scFv Fragment (HPAB-1507-FY-S(P)) | Neut, ELISA | Mouse scFv |
HPAB-1508-FY-S(P) | Mouse Anti-Dabigatran Recombinant Antibody; scFv Fragment (HPAB-1508-FY-S(P)) | Neut, ELISA | Mouse scFv |
HPAB-1509-FY-S(P) | Mouse Anti-Dabigatran Recombinant Antibody; scFv Fragment (HPAB-1509-FY-S(P)) | Neut, ELISA | Mouse scFv |
There are currently no Customer reviews or questions for TAB-H40. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.